StockData
Celularity Inc logo

Celularity Inc (CELU) stock

CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 20, 2026Score 7/30
$0.57−0.05 (-7.75%)

Close on Nov 17, 2026Market cap $18.53MP/E –Yield –

Celularity pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Celularity's pe ratio was 5.1× on Jul 31, 2023.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jul 31, 20235.1×−5.6
2022Oct 31, 202210.8×−5.3
2020Apr 30, 202016.0×–

More Celularity figures

See a number that looks wrong?